株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

RLS (むずむず脚症候群・下肢静止不能症候群)の主要13カ国市場の予測

Restless Legs Syndrome Forecast in 13 Major Markets 2016-2026

発行 Black Swan Analysis 商品コード 350838
出版日 ページ情報 英文 52 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
RLS (むずむず脚症候群・下肢静止不能症候群)の主要13カ国市場の予測 Restless Legs Syndrome Forecast in 13 Major Markets 2016-2026
出版日: 2016年01月29日 ページ情報: 英文 52 Pages
概要

当レポートでは、世界の主要13カ国におけるRLS (むずむず脚症候群・下肢静止不能症候群)の罹患状況を調査し、疾患の概要、リスク因子、疾患の診断と予後、主な症状や併存症、有病数 (性別・年齢コホート別) の推移と予測などを国別にまとめています。

調査対象国

  • 米国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • 英国
  • トルコ
  • ブラジル
  • メキシコ
  • 韓国
  • インド
  • 中国
  • 日本

目次

  • イントロダクション
  • 病因
  • リスク因子と予防
  • 疾患の診断
  • 地域/民族による違い
  • 疾患予後と臨床経過
  • 主な併存症/疾患に関連する特徴
  • 患者数を定量化法
  • 主要国のRLSの発症数
  • RLSの特徴
    • RLSのタイプ
    • 経過・重症度
  • RLS関連症状
    • 睡眠障害
    • 周期性四肢運動
    • パニック障害
    • 大うつ病性障害
  • 付録
  • 図表
目次
Product Code: REST0010116

Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disorder, is a sensimotor sleep disorder. Clinically, RLS is characterized by disagreeable leg sensations occurring most often at sleep onset that provoke an irresistible urge to move legs. Patients with RLS typically complain of itching, creeping and tingling in their legs, usually between the ankle and the knee. The unpleasant sensations occur when the individual is at rest and are more pronounced in the evening or at night. The unpleasant sensations are relieved temporarily with leg movements.

This report provides the current prevalent population for Restless Legs Syndrome across 13 Major Markets (USA, France, Germany, Italy, Spain, UK, Turkey, Brazil, Mexico, Republic of Korea, India, China and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Restless Legs Syndrome have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Restless Legs Syndrome include:

  • Insomnia
  • Depression
  • Periodic Limb Movements
  • Panic Disorder

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reasons to buy

  • Able to quantify patient populations in global Restless Legs Syndrome's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Restless Legs Syndrome and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Restless Legs Syndrome's prevalent population.
  • Identify sub-populations within Restless Legs Syndrome which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Restless Legs Syndrome patients.

COVERAGE

  • US
  • UK
  • FR
  • DE
  • IT
  • ES
  • JP
  • BR
  • CN
  • IN
  • TR
  • KR
  • MX

Table of Contents

  • List of tables and figures
  • Introduction
  • Cause of the disease
  • Risk factors & prevention
  • Diagnosis of the disease
  • Variation by geography/ethnicity
  • Disease prognosis & clinical course
  • Key comorbid conditions / features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line prevalence for restless legs syndrome
  • Features of restless legs syndrome
    • Type of restless legs syndrome
    • Course and severity of restless legs syndrome
  • Conditions associated with restless legs syndrome
    • Sleep disturbance
    • Periodic limb movements
    • Panic disorder
    • Major depressive disorder
  • Abbreviations used in the report
  • Other black swan analysis publications
  • Black swan analysis online patient-based databases
  • Patient-based offering
  • Online pricing data & platforms
  • References
  • Appendix

List of Tables

  • 1. IRLSSG Diagnostic criteria
  • 2. Prevalence of RLS, total (000s)
  • 3. Prevalence of RLS, males (000s)
  • 4. Prevalence of RLS, females (000s)
  • 5. Type of RLS in patients, total (000s)
  • 6. Prevalence of RLS with familial component, total (000s)
  • 7. Type of course in RLS patients, total (000s)
  • 8. Frequency of symptoms in INTERMITTENT RLS patients, total (000s)
  • 9. CHRONIC-PERSISTENT RLS patients ( ≥2 episodes per week), total (000s)
  • 10. Prevalence of Sleep disturbance in RLS patients, total (000s)
  • 11. Prevalence of Periodic Limb Movements in RLS patients, total (000s)
  • 12. Prevalence of Panic disorder in RLS patients, total (000s)
  • 13. Prevalence of Major Depressive Disorder in RLS patients, total (000s)
  • 14. Abbreviations and Acronyms used in the report
  • 15. USA Prevalence of RLS by 5-yr age cohort, males (000s)
  • 16. USA Prevalence of RLS by 5-yr age cohort, females (000s)
  • 17. France Prevalence of RLS by 5-yr age cohort, males (000s)
  • 18. France Prevalence of RLS by 5-yr age cohort, females (000s)
  • 19. Germany Prevalence of RLS by 5-yr age cohort, males (000s)
  • 20. Germany Prevalence of RLS by 5-yr age cohort, females (000s)
  • 21. Italy Prevalence of RLS by 5-yr age cohort, males (000s)
  • 22. Italy Prevalence of RLS by 5-yr age cohort, females (000s)
  • 23. Spain Prevalence of RLS by 5-yr age cohort, males (000s)
  • 24. Spain Prevalence of RLS by 5-yr age cohort, females (000s)
  • 25. United Kingdom Prevalence of RLS by 5-yr age cohort, males (000s)
  • 26. United Kingdom Prevalence of RLS by 5-yr age cohort, females (000s)
  • 27. Brazil Prevalence of RLS by 5-yr age cohort, males (000s)
  • 28. Brazil Prevalence of RLS by 5-yr age cohort, females (000s)
  • 29. Japan Prevalence of RLS by 5-yr age cohort, males (000s)
  • 30. Japan Prevalence of RLS by 5-yr age cohort, females (000s)
  • 31. India Prevalence of RLS by 5-yr age cohort, males (000s)
  • 32. India Prevalence of RLS by 5-yr age cohort, females (000s)
  • 33. Mexico Prevalence of RLS by 5-yr age cohort, males (000s)
  • 34. Mexico Prevalence of RLS by 5-yr age cohort, females (000s)
  • 35. Turkey Prevalence of RLS by 5-yr age cohort, males (000s)
  • 36. Turkey Prevalence of RLS by 5-yr age cohort, females (000s)
  • 37. Republic of Korea Prevalence of RLS by 5-yr age cohort, males (000s)
  • 38. Republic of Korea Prevalence of RLS by 5-yr age cohort, females (000s)
  • 39. China Prevalence of RLS by 5-yr age cohort, males (000s)
  • 40. China Prevalence of RLS by 5-yr age cohort, females (000s)
Back to Top